Clal Biotechnology

1 stories about Clal Biotechnology
תל אביב בורסה Tel Aviv Stock Exchange

Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares

23.04.18|Dror Reich
The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1